Compare Nuscale Power Corporation (SMR) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuscale Power Corporation vs Tempus AI — how do they compare? Nuscale Power Corporation trades at $9.75 (market cap $3.77B), while Tempus AI trades at $55.61 (market cap $9.93B). The key difference: Tempus AI is far larger — about 2.6× Nuscale Power Corporation's market cap, and Tempus AI is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals.
| SMR | TEM | |
|---|---|---|
Market Cap | $3.77B | $9.93B |
Sector | Utilities | Broad Market / Factor |
52-Week High | $53.43 | $103.25 |
52-Week Low | $7.59 | $41.55 |
Enterprise Value | $2.70B | $10.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NuScale Power (SMR) trades at $9.83, up 3.69% with a bullish technical signal. The company reported Q2 2026 earnings that met estimates but revenues plunged 98.8% as RoPower work wound down. Despite negative profit margins and cash burn, NuScale maintains $1.9 billion liquidity and is advancing commercialization of its NRC-approved small modular reactor technology amid growing AI power demand.
The outlook hinges on successful commercial deployment of SMR technology, with potential for significant upside if large-scale projects materialize. Key risks include execution challenges, revenue volatility, and intense competition in the nuclear energy sector. Analyst consensus suggests 8% upside to the $10.63 price target, but investors should weigh the high-risk, high-reward nature of this pre-revenue growth story.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuscale Power Corporation
NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.
Read more on SMR →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
